Page 4 - Dr Reddys
Dr Reddy's Labs slumps 8% as US FDA issues CRL for its version of NuvaRing
A CRL is issued when the FDA decides not to approve new or generic drug application for marketing in its present form
 "Dr Reddy's Labs slumps 8% as US FDA issues CRL for its version of NuvaRing")
Updated On : 14 Aug 2019 | 10:51 AM IST
Dr Reddy's launches insomnia treatment tablets in US after FDA approval
The product is a generic version of Takeda Pharmaceutical Company's Rozerem tablets in the same strength
Updated On : 23 Jul 2019 | 4:57 PM IST
Dr Reddy's closes sale of US, select territory rights for neurology drugs
Under the agreement, Dr Reddy's sold its US and select territory rights for Zembrace Symtouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg
 "Dr Reddy's closes sale of US, select territory rights for neurology drugs")
Updated On : 21 Jul 2019 | 1:17 AM IST
Dr Reddy's Laboratories unveils generic version of Allegra-D in US
Allegra-D 12 HR is a trademark of Aventisub II Inc
 "Dr Reddy's Laboratories unveils generic version of Allegra-D in US")
Updated On : 19 Jul 2019 | 2:55 PM IST
Dr Reddy's Laboratories launches generic anti-cancer drug in US market
Gleevec and its generic equivalents saw sales of approximately $868 mn in the US for the last twelve months ending in July 2018
 "Dr Reddy's Laboratories launches generic anti-cancer drug in US market")
Updated On : 01 Oct 2018 | 10:43 PM IST
